Entrada Therapeutics Inc.

Entrada Therapeutics Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Entrada Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 875000, a 95.74% decrease year-over-year.
• Entrada Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 25.0 M, a 88.49% decrease year-over-year.
• Entrada Therapeutics Inc. annual revenue for 2025 was 25.4 M, a 87.94% decrease from 2024.
• Entrada Therapeutics Inc. annual revenue for 2024 was 210.8 M, a 63.38% increase from 2023.
• Entrada Therapeutics Inc. annual revenue for 2023 was 129.0 M.